INIS
vaccines
100%
viruses
100%
humans
100%
antigens
53%
vectors
53%
dna
50%
hiv
50%
glycoproteins
27%
ebola viruses
17%
protection
13%
antibodies
13%
primates
10%
risks
10%
diseases
10%
interactions
10%
production
10%
populations
10%
animals
7%
particles
7%
Immunology and Microbiology
Vesiculovirus
50%
Rhesus Monkey
50%
Viral Vector
50%
Human Immunodeficiency Virus Antigen
50%
Vaccine Efficacy
50%
Viremia
50%
Vesiculovirus
50%
Glycoprotein
33%
Human Immunodeficiency Virus
33%
Cladistics
16%
Viral Envelope
16%
Primate
16%
Population Risk
16%
Ebola Virus
16%
Upregulation
16%
CD154
16%
CD69
16%
Memory T Cell
16%
Monospecific Antibody
16%
